E3 ubiquitin ligases in cancer and implications for therapies (original) (raw)
References
Wilkinson, K. D. (1987). Protein ubiquitination: a regulatory post-translational modification. Anti-Cancer Drug Design, 2(2), 211–229. CASPubMed Google Scholar
Hershko, A. (1983). Ubiquitin: roles in protein modification and breakdown. Cell, 34(1), 11–12. ArticleCASPubMed Google Scholar
Lianhua, D., Maoliang, R., Zhi, L., Fuzhi, P., & Bin, C. (2016). The role of ubiquitin-proteasome pathway in spermatogenesis. Yi Chuan Hereditas, 38(9), 791–800. https://doi.org/10.16288/j.yczz.16-120. Google Scholar
Okamoto, Y., Ozaki, T., Miyazaki, K., Aoyama, M., Miyazaki, M., & Nakagawara, A. (2003). UbcH10 is the cancer-related E2 ubiquitin-conjugating enzyme. Cancer Research, 63(14), 4167–4173. CASPubMed Google Scholar
Bedford, L., Lowe, J., Dick, L. R., Mayer, R. J., & Brownell, J. E. (2011). Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nature Reviews Drug Discovery, 10(1), 29–46. https://doi.org/10.1038/nrd3321. ArticleCASPubMed Google Scholar
Orlowski, R. Z., & Baldwin Jr., A. S. (2002). NF-kappaB as a therapeutic target in cancer. Trends in Molecular Medicine, 8(8), 385–389. ArticleCASPubMed Google Scholar
Huibregtse, J. M., Scheffner, M., Beaudenon, S., & Howley, P. M. (1995). A family of proteins structurally and functionally related to the E6-AP ubiquitin-protein ligase. Proceedings of the National Academy of Sciences of the United States of America, 92(11), 5249. ArticleCASPubMedPubMed Central Google Scholar
Nomine, Y., Masson, M., Charbonnier, S., Zanier, K., Ristriani, T., Deryckere, F., et al. (2006). Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Molecular Cell, 21(5), 665–678. https://doi.org/10.1016/j.molcel.2006.01.024. ArticleCASPubMed Google Scholar
Vander Kooi, C. W., Ohi, M. D., Rosenberg, J. A., Oldham, M. L., Newcomer, M. E., Gould, K. L., et al. (2006). The Prp19 U-box crystal structure suggests a common dimeric architecture for a class of oligomeric E3 ubiquitin ligases. Biochemistry, 45(1), 121–130. https://doi.org/10.1021/bi051787e. ArticleCASPubMedPubMed Central Google Scholar
Kucharski, T. J., Minshall, P. E., Moustafa-Kamal, M., Turnell, A. S., & Teodoro, J. G. (2017). Reciprocal regulation between 53BP1 and the anaphase-promoting complex/cyclosome is required for genomic stability during mitotic stress. Cell Reports, 18(8), 1982–1995. https://doi.org/10.1016/j.celrep.2017.01.080. ArticleCASPubMed Google Scholar
March, H. N., Rust, A. G., Wright, N. A., ten Hoeve, J., de Ridder, J., Eldridge, M., et al. (2011). Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis. Nature Genetics, 43(12), 1202–1209. https://doi.org/10.1038/ng.990. ArticleCASPubMedPubMed Central Google Scholar
Eide, P. W., Cekaite, L., Danielsen, S. A., Eilertsen, I. A., Kjenseth, A., Fykerud, T. A., et al. (2013). NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway. Cellular Signalling, 25(1), 12–18. https://doi.org/10.1016/j.cellsig.2012.08.012. ArticleCASPubMed Google Scholar
Kim, S. S., Yoo, N. J., Jeong, E. G., Kim, M. S., & Lee, S. H. (2008). Expression of NEDD4-1, a PTEN regulator, in gastric and colorectal carcinomas. APMIS (Acta Pathologica, Microbiologica, et Immunologica Scandinavica), 116(9), 779–784. Article Google Scholar
Qi, H., Grenier, J., Fournier, A., & Labrie, C. (2003). Androgens differentially regulate the expression of NEDD4L transcripts in LNCaP human prostate cancer cells. Molecular and Cellular Endocrinology, 210(1–2), 51–62. ArticleCASPubMed Google Scholar
Booken, N., Gratchev, A., Utikal, J., Weiss, C., Yu, X., Qadoumi, M., et al. (2008). Sezary syndrome is a unique cutaneous T-cell lymphoma as identified by an expanded gene signature including diagnostic marker molecules CDO1 and DNM3. Leukemia, 22(2), 393–399. https://doi.org/10.1038/sj.leu.2405044. ArticleCASPubMed Google Scholar
Hu, X. Y., Xu, Y. M., Fu, Q., Yu, J. J., & Huang, J. (2009). Nedd4L expression is downregulated in prostate cancer compared to benign prostatic hyperplasia. European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 35(5), 527–531. https://doi.org/10.1016/j.ejso.2008.09.015. ArticleCAS Google Scholar
Qu, M. H., Han, C., Srivastava, A. K., Cui, T., Zou, N., Gao, Z. Q., et al. (2016). miR-93 promotes TGF-beta-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells. Tumour Biology, 37(4), 5645–5651. https://doi.org/10.1007/s13277-015-4328-8. ArticleCASPubMed Google Scholar
Kito, Y., Bai, J., Goto, N., Okubo, H., Adachi, Y., Nagayama, T., et al. (2014). Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma. International Journal of Experimental Pathology, 95(1), 24–28. https://doi.org/10.1111/iep.12051. ArticleCASPubMed Google Scholar
Frampton, A. E., Castellano, L., Colombo, T., Giovannetti, E., Krell, J., Jacob, J., et al. (2014). MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. Gastroenterology, 146(1), 268–277 e218. https://doi.org/10.1053/j.gastro.2013.10.010. ArticleCASPubMed Google Scholar
Sampath, D., Calin, G. A., Puduvalli, V. K., Gopisetty, G., Taccioli, C., Liu, C. G., et al. (2009). Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood, 113(16), 3744–3753. https://doi.org/10.1182/blood-2008-09-178707. ArticleCASPubMedPubMed Central Google Scholar
Fukuchi, M., Fukai, Y., Masuda, N., Miyazaki, T., Nakajima, M., Sohda, M., et al. (2002). High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Research, 62(24), 7162–7165. CASPubMed Google Scholar
Loukopoulos, P., Shibata, T., Katoh, H., Kokubu, A., Sakamoto, M., Yamazaki, K., et al. (2007). Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome. Cancer Science, 98(3), 392–400. https://doi.org/10.1111/j.1349-7006.2007.00395.x. ArticleCASPubMed Google Scholar
Fukasawa, H., Yamamoto, T., Fujigaki, Y., Misaki, T., Ohashi, N., Takayama, T., et al. (2010). Reduction of transforming growth factor-beta type II receptor is caused by the enhanced ubiquitin-dependent degradation in human renal cell carcinoma. International Journal of Cancer, 127(7), 1517–1525. https://doi.org/10.1002/ijc.25164. ArticleCASPubMed Google Scholar
Wu, Z., Zan, P., Li, S., Liu, J., Wang, J., Chen, D., et al. (2015). Knockdown of WWP1 inhibits growth and invasion, but induces apoptosis of osteosarcoma cells. International Journal of Clinical and Experimental Pathology, 8(7), 7869–7877. CASPubMedPubMed Central Google Scholar
Qian, Y. W., Chen, Y., Yang, W., Fu, J., Cao, J., Ren, Y. B., et al. (2012). p28(GANK) prevents degradation of Oct4 and promotes expansion of tumor-initiating cells in hepatocarcinogenesis. Gastroenterology, 142(7), 1547–1558 e1514. https://doi.org/10.1053/j.gastro.2012.02.042. ArticleCASPubMed Google Scholar
Yang, R., He, Y., Chen, S., Lu, X., Huang, C., & Zhang, G. (2016). Elevated expression of WWP2 in human lung adenocarcinoma and its effect on migration and invasion. Biochemical and Biophysical Research Communications, 479(2), 146–151. https://doi.org/10.1016/j.bbrc.2016.07.084. ArticleCASPubMed Google Scholar
Diouf, B., Cheng, Q., Krynetskaia, N. F., Yang, W., Cheok, M., Pei, D., et al. (2011). Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells. Nature Medicine, 17(10), 1298–1303. https://doi.org/10.1038/nm.2430. ArticleCASPubMedPubMed Central Google Scholar
Gamell, C., Gulati, T., Levav-Cohen, Y., Young, R. J., Do, H., Pilling, P., et al. (2017). Reduced abundance of the E3 ubiquitin ligase E6AP contributes to decreased expression of the INK4/ARF locus in non-small cell lung cancer. Science Signaling, 10(461). https://doi.org/10.1126/scisignal.aaf8223.
Paul, P. J., Raghu, D., Chan, A. L., Gulati, T., Lambeth, L., Takano, E., et al. (2016). Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP. Oncogene, 35(48), 6235–6245. https://doi.org/10.1038/onc.2016.159. ArticleCASPubMed Google Scholar
Mayo, L. D., Dixon, J. E., Durden, D. L., Tonks, N. K., & Donner, D. B. (2002). PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. The Journal of Biological Chemistry, 277(7), 5484–5489. https://doi.org/10.1074/jbc.M108302200. ArticleCASPubMed Google Scholar
Wang, X. M., Yang, L. Y., Guo, L., Fan, C., & Wu, F. (2009). p53-Induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Cancer, 115(19), 4554–4563. https://doi.org/10.1002/cncr.24494. ArticleCASPubMed Google Scholar
Duan, W., Gao, L., Druhan, L. J., Zhu, W. G., Morrison, C., Otterson, G. A., et al. (2004). Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer. Journal of the National Cancer Institute, 96(22), 1718–1721. https://doi.org/10.1093/jnci/djh292. ArticleCASPubMed Google Scholar
Logan, I. R., Gaughan, L., McCracken, S. R., Sapountzi, V., Leung, H. Y., & Robson, C. N. (2006). Human PIRH2 enhances androgen receptor signaling through inhibition of histone deacetylase 1 and is overexpressed in prostate cancer. Molecular and Cellular Biology, 26(17), 6502–6510. https://doi.org/10.1128/MCB.00147-06. ArticleCASPubMedPubMed Central Google Scholar
Shimada, M., Kitagawa, K., Dobashi, Y., Isobe, T., Hattori, T., Uchida, C., et al. (2009). High expression of Pirh2, an E3 ligase for p27, is associated with low expression of p27 and poor prognosis in head and neck cancers. Cancer Science, 100(5), 866–872. ArticleCASPubMed Google Scholar
Korphaisarn, K., Morris, V. K., Overman, M. J., Fogelman, D. R., Kee, B. K., Raghav, K. P. S., et al. (2017). FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma. Oncotarget, 8(24), 39268–39279. https://doi.org/10.18632/oncotarget.16848. PubMedPubMed Central Google Scholar
Xu, J., Wu, W., Wang, J., Huang, C., Wen, W., Zhao, F., et al. (2017). miR-367 promotes the proliferation and invasion of non-small cell lung cancer via targeting FBXW7. Oncology Reports, 37(2), 1052–1058. https://doi.org/10.3892/or.2016.5314. ArticlePubMed Google Scholar
Gong, J., Cui, Z., Li, L., Ma, Q., Wang, Q., Gao, Y., et al. (2015). MicroRNA-25 promotes gastric cancer proliferation, invasion, and migration by directly targeting F-box and WD-40 Domain Protein 7, FBXW7. Tumour Biology, 36(10), 7831–7840. https://doi.org/10.1007/s13277-015-3510-3. ArticleCASPubMed Google Scholar
Tosco, P., La Terra Maggiore, G. M., Forni, P., Berrone, S., Chiusa, L., & Garzino-Demo, P. (2011). Correlation between Skp2 expression and nodal metastasis in stage I and II oral squamous cell carcinomas. Oral Diseases, 17(1), 102–108. https://doi.org/10.1111/j.1601-0825.2010.01713.x. ArticleCASPubMed Google Scholar
Gerstein, A. V., Almeida, T. A., Zhao, G., Chess, E., Shih Ie, M., Buhler, K., et al. (2002). APC/CTNNB1 (beta-catenin) pathway alterations in human prostate cancers. Genes, Chromosomes & Cancer, 34(1), 9–16. ArticleCAS Google Scholar
Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V., Mai, M., Fuchs, S. Y., et al. (2004). Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer. Journal of the National Cancer Institute, 96(15), 1161–1170. https://doi.org/10.1093/jnci/djh219. ArticleCASPubMed Google Scholar
Muerkoster, S., Arlt, A., Sipos, B., Witt, M., Grossmann, M., Kloppel, G., et al. (2005). Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells. Cancer Research, 65(4), 1316–1324. https://doi.org/10.1158/0008-5472.CAN-04-1626. ArticlePubMed Google Scholar
Liu, H., Cheng, E. H., & Hsieh, J. J. (2007). Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes & Development, 21(19), 2385–2398. https://doi.org/10.1101/gad.1574507. ArticleCAS Google Scholar
Kato, T., Daigo, Y., Aragaki, M., Ishikawa, K., Sato, M., & Kaji, M. (2012). Overexpression of CDC20 predicts poor prognosis in primary non-small cell lung cancer patients. Journal of Surgical Oncology, 106(4), 423–430. https://doi.org/10.1002/jso.23109. ArticleCASPubMed Google Scholar
Manchado, E., Guillamot, M., de Carcer, G., Eguren, M., Trickey, M., Garcia-Higuera, I., et al. (2010). Targeting mitotic exit leads to tumor regression in vivo: modulation by Cdk1, Mastl, and the PP2A/B55alpha,delta phosphatase. Cancer Cell, 18(6), 641–654. https://doi.org/10.1016/j.ccr.2010.10.028. ArticleCASPubMed Google Scholar
Fujita, T., Liu, W., Doihara, H., Date, H., & Wan, Y. (2008). Dissection of the APCCdh1-Skp2 cascade in breast cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 14(7), 1966–1975. https://doi.org/10.1158/1078-0432.CCR-07-1585. ArticleCAS Google Scholar
Burger, A. M., Gao, Y., Amemiya, Y., Kahn, H. J., Kitching, R., Yang, Y., et al. (2005). A novel RING-type ubiquitin ligase breast cancer-associated gene 2 correlates with outcome in invasive breast cancer. Cancer Research, 65(22), 10401–10412. https://doi.org/10.1158/0008-5472.CAN-05-2103. ArticleCASPubMed Google Scholar
Veeriah, S., Taylor, B. S., Meng, S., Fang, F., Yilmaz, E., Vivanco, I., et al. (2010). Somatic mutations of the Parkinson’s disease-associated gene PARK2 in glioblastoma and other human malignancies. Nature Genetics, 42(1), 77–82. https://doi.org/10.1038/ng.491. ArticleCASPubMed Google Scholar
Poulogiannis, G., McIntyre, R. E., Dimitriadi, M., Apps, J. R., Wilson, C. H., Ichimura, K., et al. (2010). PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice. Proceedings of the National Academy of Sciences of the United States of America, 107(34), 15145–15150. https://doi.org/10.1073/pnas.1009941107. ArticleCASPubMedPubMed Central Google Scholar
Cesari, R., Martin, E. S., Calin, G. A., Pentimalli, F., Bichi, R., McAdams, H., et al. (2003). Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proceedings of the National Academy of Sciences of the United States of America, 100(10), 5956–5961. https://doi.org/10.1073/pnas.0931262100. ArticleCASPubMedPubMed Central Google Scholar
Quinsay, M. N., Lee, Y., Rikka, S., Sayen, M. R., Molkentin, J. D., Gottlieb, R. A., et al. (2010). Bnip3 mediates permeabilization of mitochondria and release of cytochrome c via a novel mechanism. Journal of Molecular and Cellular Cardiology, 48(6), 1146–1156. https://doi.org/10.1016/j.yjmcc.2009.12.004. ArticleCASPubMed Google Scholar
Kumar, S., Tomooka, Y., & Noda, M. (1992). Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochemical and Biophysical Research Communications, 185(3), 1155–1161. ArticleCASPubMed Google Scholar
Harvey, K. F., & Kumar, S. (1999). Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions. Trends in Cell Biology, 9(5), 166–169. ArticleCASPubMed Google Scholar
Yang, B., Gay, D. L., MacLeod, M. K., Cao, X., Hala, T., Sweezer, E. M., et al. (2008). Nedd4 augments the adaptive immune response by promoting ubiquitin-mediated degradation of Cbl-b in activated T cells. Nature Immunology, 9(12), 1356–1363. https://doi.org/10.1038/ni.1670. ArticleCASPubMedPubMed Central Google Scholar
Ing, B., Shteiman-Kotler, A., Castelli, M., Henry, P., Pak, Y., Stewart, B., et al. (2007). Regulation of Commissureless by the ubiquitin ligase DNedd4 is required for neuromuscular synaptogenesis in Drosophila melanogaster. Molecular and Cellular Biology, 27(2), 481–496. https://doi.org/10.1128/MCB.00463-06. ArticleCASPubMed Google Scholar
Fouladkou, F., Lu, C., Jiang, C., Zhou, L., She, Y., Walls, J. R., et al. (2010). The ubiquitin ligase Nedd4-1 is required for heart development and is a suppressor of thrombospondin-1. The Journal of Biological Chemistry, 285(9), 6770–6780. https://doi.org/10.1074/jbc.M109.082347. ArticleCASPubMed Google Scholar
Uchida, C., & Kitagawa, M. (2016). RING-, HECT-, and RBR-type E3 ubiquitin ligases: involvement in human cancer. Current Cancer Drug Targets, 16(2), 157–174. ArticleCASPubMed Google Scholar
Araki, N., Umemura, M., Miyagi, Y., Yabana, M., Miki, Y., Tamura, K., et al. (2008). Expression, transcription, and possible antagonistic interaction of the human Nedd4L gene variant: implications for essential hypertension. Hypertension, 51(3), 773–777. https://doi.org/10.1161/HYPERTENSIONAHA.107.102061. ArticleCASPubMed Google Scholar
Ronzaud, C., Loffing-Cueni, D., Hausel, P., Debonneville, A., Malsure, S. R., Fowler-Jaeger, N., et al. (2013). Renal tubular NEDD4-2 deficiency causes NCC-mediated salt-dependent hypertension. The Journal of Clinical Investigation, 123(2), 657–665. https://doi.org/10.1172/JCI61110. CASPubMedPubMed Central Google Scholar
Hustad, C. M., Perry, W. L., Siracusa, L. D., Rasberry, C., Cobb, L., Cattanach, B. M., et al. (1995). Molecular genetic characterization of six recessive viable alleles of the mouse agouti locus. Genetics, 140(1), 255–265. CASPubMedPubMed Central Google Scholar
Abedini, M. R., Muller, E. J., Brun, J., Bergeron, R., Gray, D. A., & Tsang, B. K. (2008). Cisplatin induces p53-dependent FLICE-like inhibitory protein ubiquitination in ovarian cancer cells. Cancer Research, 68(12), 4511–4517. https://doi.org/10.1158/0008-5472.CAN-08-0673. ArticleCASPubMed Google Scholar
Fukunaga, E., Inoue, Y., Komiya, S., Horiguchi, K., Goto, K., Saitoh, M., et al. (2008). Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells. The Journal of Biological Chemistry, 283(51), 35660–35667. https://doi.org/10.1074/jbc.M710496200. ArticleCASPubMed Google Scholar
Blank, M., Tang, Y., Yamashita, M., Burkett, S. S., Cheng, S. Y., & Zhang, Y. E. (2012). A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nature Medicine, 18(2), 227–234. https://doi.org/10.1038/nm.2596. ArticleCASPubMedPubMed Central Google Scholar
Chen, C., Zhou, Z., Liu, R., Li, Y., Azmi, P. B., & Seth, A. K. (2008). The WW domain containing E3 ubiquitin protein ligase 1 upregulates ErbB2 and EGFR through RING finger protein 11. Oncogene, 27(54), 6845–6855. https://doi.org/10.1038/onc.2008.288. ArticleCASPubMed Google Scholar
Seto, M. H., Liu, H. L., Zajchowski, D. A., & Whitlow, M. (1999). Protein fold analysis of the B30.2-like domain. Proteins, 35(2), 235–249. ArticleCASPubMed Google Scholar
Tae, H., Wei, L., Willemse, H., Mirza, S., Gallant, E. M., Board, P. G., et al. (2011). The elusive role of the SPRY2 domain in RyR1. Channels, 5(2), 148–160. ArticleCASPubMedPubMed Central Google Scholar
Garcia-Gonzalo, F. R., Cruz, C., Munoz, P., Mazurek, S., Eigenbrodt, E., Ventura, F., et al. (2003). Interaction between HERC1 and M2-type pyruvate kinase. FEBS Letters, 539(1–3), 78–84. ArticleCASPubMed Google Scholar
Utine, G. E., Taskiran, E. Z., Kosukcu, C., Karaosmanoglu, B., Guleray, N., Dogan, O. A., et al. (2017). HERC1 mutations in idiopathic intellectual disability. European Journal of Medical Genetics, 60(5), 279–283. https://doi.org/10.1016/j.ejmg.2017.03.007. ArticlePubMed Google Scholar
Rosa, J. L., Casaroli-Marano, R. P., Buckler, A. J., Vilaro, S., & Barbacid, M. (1996). p619, a giant protein related to the chromosome condensation regulator RCC1, stimulates guanine nucleotide exchange on ARF1 and Rab proteins. The EMBO Journal, 15(16), 4262–4273. CASPubMedPubMed Central Google Scholar
Sanchez-Tena, S., Cubillos-Rojas, M., Schneider, T., & Rosa, J. L. (2016). Functional and pathological relevance of HERC family proteins: a decade later. Cellular and Molecular Life Sciences: CMLS, 73(10), 1955–1968. https://doi.org/10.1007/s00018-016-2139-8. ArticleCASPubMed Google Scholar
Kang, T. H., Lindsey-Boltz, L. A., Reardon, J. T., & Sancar, A. (2010). Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase. Proceedings of the National Academy of Sciences of the United States of America, 107(11), 4890–4895. https://doi.org/10.1073/pnas.0915085107. ArticleCASPubMedPubMed Central Google Scholar
Bekker-Jensen, S., Rendtlew Danielsen, J., Fugger, K., Gromova, I., Nerstedt, A., Lukas, C., et al. (2010). HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes. Nature Cell Biology, 12(1), 80–86; sup pp 81–12. https://doi.org/10.1038/ncb2008. ArticleCASPubMed Google Scholar
Al-Hakim, A. K., Bashkurov, M., Gingras, A. C., Durocher, D., & Pelletier, L. (2012). Interaction proteomics identify NEURL4 and the HECT E3 ligase HERC2 as novel modulators of centrosome architecture. Molecular & Cellular Proteomics, 11(6), M111 014233. https://doi.org/10.1074/mcp.M111.014233. ArticleCAS Google Scholar
Chan, N. C., den Besten, W., Sweredoski, M. J., Hess, S., Deshaies, R. J., & Chan, D. C. (2014). Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2. The Journal of Biological Chemistry, 289(28), 19789–19798. https://doi.org/10.1074/jbc.M114.569392. ArticleCASPubMedPubMed Central Google Scholar
Mancias, J. D., Pontano Vaites, L., Nissim, S., Biancur, D. E., Kim, A. J., Wang, X., et al. (2015). Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. eLife, 4. https://doi.org/10.7554/eLife.10308.
Kang, T. H., Reardon, J. T., & Sancar, A. (2011). Regulation of nucleotide excision repair activity by transcriptional and post-transcriptional control of the XPA protein. Nucleic Acids Research, 39(8), 3176–3187. https://doi.org/10.1093/nar/gkq1318. ArticleCASPubMed Google Scholar
Oda, H., Kumar, S., & Howley, P. M. (1999). Regulation of the Src family tyrosine kinase Blk through E6AP-mediated ubiquitination. Proceedings of the National Academy of Sciences of the United States of America, 96(17), 9557–9562. ArticleCASPubMedPubMed Central Google Scholar
Kuhne, C., & Banks, L. (1998). E3-ubiquitin ligase/E6-AP links multicopy maintenance protein 7 to the ubiquitination pathway by a novel motif, the L2G box. The Journal of Biological Chemistry, 273(51), 34302–34309. ArticleCASPubMed Google Scholar
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991). A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. The EMBO Journal, 10(13), 4129–4135. CASPubMedPubMed Central Google Scholar
Olivos, D. J., & Mayo, L. D. (2016). Emerging non-canonical functions and regulation by p53: p53 and stemness. International Journal of Molecular Sciences, 17(12). https://doi.org/10.3390/ijms17121982.
Sehat, B., Andersson, S., Girnita, L., & Larsson, O. (2008). Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis. Cancer Research, 68(14), 5669–5677. https://doi.org/10.1158/0008-5472.CAN-07-6364. ArticleCASPubMed Google Scholar
Yu, G. W., Rudiger, S., Veprintsev, D., Freund, S., Fernandez-Fernandez, M. R., & Fersht, A. R. (2006). The central region of HDM2 provides a second binding site for p53. Proceedings of the National Academy of Sciences of the United States of America, 103(5), 1227–1232. https://doi.org/10.1073/pnas.0510343103. ArticleCASPubMedPubMed Central Google Scholar
Gajjar, M., Candeias, M. M., Malbert-Colas, L., Mazars, A., Fujita, J., Olivares-Illana, V., et al. (2012). The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell, 21(1), 25–35. https://doi.org/10.1016/j.ccr.2011.11.016. ArticleCASPubMed Google Scholar
Candeias, M. M., Malbert-Colas, L., Powell, D. J., Daskalogianni, C., Maslon, M. M., Naski, N., et al. (2008). P53 mRNA controls p53 activity by managing Mdm2 functions. Nature Cell Biology, 10(9), 1098–1105. https://doi.org/10.1038/ncb1770. ArticleCASPubMed Google Scholar
Pant, V., Xiong, S., Iwakuma, T., Quintas-Cardama, A., & Lozano, G. (2011). Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proceedings of the National Academy of Sciences of the United States of America, 108(29), 11995–12000. https://doi.org/10.1073/pnas.1102241108. ArticleCASPubMedPubMed Central Google Scholar
Sheng, Y., Laister, R. C., Lemak, A., Wu, B., Tai, E., Duan, S., et al. (2008). Molecular basis of Pirh2-mediated p53 ubiquitylation. Nature Structural & Molecular Biology, 15(12), 1334–1342. https://doi.org/10.1038/nsmb.1521. ArticleCAS Google Scholar
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., et al. (2003). Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell, 112(6), 779–791. ArticleCASPubMed Google Scholar
Li, Q., Lin, S., Wang, X., Lian, G., Lu, Z., Guo, H., et al. (2009). Axin determines cell fate by controlling the p53 activation threshold after DNA damage. Nature Cell Biology, 11(9), 1128–1134. ArticleCASPubMed Google Scholar
Wang, H., Kang, D., Deng, X. W., & Wei, N. (1999). Evidence for functional conservation of a mammalian homologue of the light-responsive plant protein COP1. Current Biology: CB, 9(13), 711–714. ArticleCASPubMed Google Scholar
Migliorini, D., Bogaerts, S., Defever, D., Vyas, R., Denecker, G., Radaelli, E., et al. (2011). Cop1 constitutively regulates c-Jun protein stability and functions as a tumor suppressor in mice. The Journal of Clinical Investigation, 121(4), 1329–1343. https://doi.org/10.1172/JCI45784. ArticleCASPubMedPubMed Central Google Scholar
Nash, P., Tang, X., Orlicky, S., Chen, Q., Gertler, F. B., Mendenhall, M. D., et al. (2001). Multisite phosphorylation of a CDK inhibitor sets a threshold for the onset of DNA replication. Nature, 414(6863), 514–521. https://doi.org/10.1038/35107009. ArticleCASPubMed Google Scholar
Welcker, M., Orian, A., Jin, J., Grim, J. E., Harper, J. W., Eisenman, R. N., et al. (2004). The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation. Proceedings of the National Academy of Sciences of the United States of America, 101(24), 9085–9090. https://doi.org/10.1073/pnas.0402770101. ArticleCASPubMedPubMed Central Google Scholar
Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., et al. (2001). Phosphorylation-dependent ubiquitination of cyclin E by the SCFFbw7 ubiquitin ligase. Science, 294(5540), 173–177. https://doi.org/10.1126/science.1065203. ArticleCASPubMed Google Scholar
Tetzlaff, M. T., Yu, W., Li, M., Zhang, P., Finegold, M., Mahon, K., et al. (2004). Defective cardiovascular development and elevated cyclin E and Notch proteins in mice lacking the Fbw7 F-box protein. Proceedings of the National Academy of Sciences of the United States of America, 101(10), 3338–3345. https://doi.org/10.1073/pnas.0307875101. ArticleCASPubMedPubMed Central Google Scholar
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M., Harper, J. W., et al. (1996). SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box. Cell, 86(2), 263–274. ArticleCASPubMed Google Scholar
Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., & Zhang, H. (1999). p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Current Biology: CB, 9(12), 661–664. ArticleCASPubMed Google Scholar
Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., & Hershko, A. (2003). Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. The Journal of Biological Chemistry, 278(28), 25752–25757. https://doi.org/10.1074/jbc.M301774200. ArticleCASPubMed Google Scholar
Kamura, T., Hara, T., Kotoshiba, S., Yada, M., Ishida, N., Imaki, H., et al. (2003). Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation. Proceedings of the National Academy of Sciences of the United States of America, 100(18), 10231–10236. https://doi.org/10.1073/pnas.1831009100. ArticleCASPubMedPubMed Central Google Scholar
Nakayama, K., Nagahama, H., Minamishima, Y. A., Matsumoto, M., Nakamichi, I., Kitagawa, K., et al. (2000). Targeted disruption of Skp2 results in accumulation of cyclin E and p27(Kip1), polyploidy and centrosome overduplication. The EMBO Journal, 19(9), 2069–2081. https://doi.org/10.1093/emboj/19.9.2069. ArticleCASPubMedPubMed Central Google Scholar
Yu, Z. K., Gervais, J. L., & Zhang, H. (1998). Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proceedings of the National Academy of Sciences of the United States of America, 95(19), 11324–11329. ArticleCASPubMedPubMed Central Google Scholar
Yaron, A., Hatzubai, A., Davis, M., Lavon, I., Amit, S., Manning, A. M., et al. (1998). Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature, 396(6711), 590–594. https://doi.org/10.1038/25159. ArticleCASPubMed Google Scholar
Nakayama, K., Hatakeyama, S., Maruyama, S., Kikuchi, A., Onoe, K., Good, R. A., et al. (2003). Impaired degradation of inhibitory subunit of NF-kappa B (I kappa B) and beta-catenin as a result of targeted disruption of the beta-TrCP1 gene. Proceedings of the National Academy of Sciences of the United States of America, 100(15), 8752–8757. https://doi.org/10.1073/pnas.1133216100. ArticleCASPubMedPubMed Central Google Scholar
Ding, Q., He, X., Hsu, J. M., Xia, W., Chen, C. T., Li, L. Y., et al. (2007). Degradation of Mcl-1 by beta-TrCP mediates glycogen synthase kinase 3-induced tumor suppression and chemosensitization. Molecular and Cellular Biology, 27(11), 4006–4017. https://doi.org/10.1128/MCB.00620-06. ArticleCASPubMed Google Scholar
Dorrello, N. V., Peschiaroli, A., Guardavaccaro, D., Colburn, N. H., Sherman, N. E., & Pagano, M. (2006). S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth. Science, 314(5798), 467–471. https://doi.org/10.1126/science.1130276. ArticleCASPubMed Google Scholar
Spencer, E., Jiang, J., & Chen, Z. J. (1999). Signal-induced ubiquitination of IkappaBalpha by the F-box protein Slimb/beta-TrCP. Genes & Development, 13(3), 284–294. ArticleCAS Google Scholar
Belaidouni, N., Peuchmaur, M., Perret, C., Florentin, A., Benarous, R., & Besnard-Guerin, C. (2005). Overexpression of human beta TrCP1 deleted of its F box induces tumorigenesis in transgenic mice. Oncogene, 24(13), 2271–2276. https://doi.org/10.1038/sj.onc.1208418. ArticleCASPubMed Google Scholar
Boekhout, M., & Wolthuis, R. (2015). Nek2A destruction marks APC/C activation at the prophase-to-prometaphase transition by spindle-checkpoint-restricted Cdc20. Journal of Cell Science, 128(8), 1639–1653. https://doi.org/10.1242/jcs.163279. ArticleCASPubMed Google Scholar
Peters, J. M. (2002). The anaphase-promoting complex: proteolysis in mitosis and beyond. Molecular Cell, 9(5), 931–943. ArticleCASPubMed Google Scholar
Visintin, R., Craig, K., Hwang, E. S., Prinz, S., Tyers, M., & Amon, A. (1998). The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. Molecular Cell, 2(6), 709–718. ArticleCASPubMed Google Scholar
Huang, J. N., Park, I., Ellingson, E., Littlepage, L. E., & Pellman, D. (2001). Activity of the APC(Cdh1) form of the anaphase-promoting complex persists until S phase and prevents the premature expression of Cdc20p. The Journal of Cell Biology, 154(1), 85–94. ArticleCASPubMedPubMed Central Google Scholar
Littlepage, L. E., & Ruderman, J. V. (2002). Identification of a new APC/C recognition domain, the A box, which is required for the Cdh1-dependent destruction of the kinase Aurora-A during mitotic exit. Genes & Development, 16(17), 2274–2285. https://doi.org/10.1101/gad.1007302. ArticleCAS Google Scholar
Donzelli, M., Squatrito, M., Ganoth, D., Hershko, A., Pagano, M., & Draetta, G. F. (2002). Dual mode of degradation of Cdc25 A phosphatase. The EMBO Journal, 21(18), 4875–4884. ArticleCASPubMedPubMed Central Google Scholar
Wang, Q., Moyret-Lalle, C., Couzon, F., Surbiguet-Clippe, C., Saurin, J. C., Lorca, T., et al. (2003). Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene, 22(10), 1486–1490. https://doi.org/10.1038/sj.onc.1206224. ArticleCASPubMed Google Scholar
Burger, A. M., Kona, F., Amemiya, Y., Gao, Y., Bacopulos, S., & Seth, A. K. (2010). Role of the BCA2 ubiquitin E3 ligase in hormone responsive breast cancer. The Open Cancer Journal, 3(1), 116–123. ArticleCASPubMedPubMed Central Google Scholar
Buac, D., Kona, F. R., Seth, A. K., & Dou, Q. P. (2013). Regulation of metformin response by breast cancer associated gene 2. Neoplasia, 15(12), 1379–1390. ArticlePubMedPubMed CentralCAS Google Scholar
Gegg, M. E., Cooper, J. M., Chau, K. Y., Rojo, M., Schapira, A. H., & Taanman, J. W. (2010). Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy. Human Molecular Genetics, 19(24), 4861–4870. https://doi.org/10.1093/hmg/ddq419. ArticleCASPubMedPubMed Central Google Scholar
Bertolin, G., Ferrando-Miguel, R., Jacoupy, M., Traver, S., Grenier, K., Greene, A. W., et al. (2013). The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance. Autophagy, 9(11), 1801–1817. https://doi.org/10.4161/auto.25884. ArticleCASPubMed Google Scholar
Geisler, S., Holmstrom, K. M., Skujat, D., Fiesel, F. C., Rothfuss, O. C., Kahle, P. J., et al. (2010). PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nature Cell Biology, 12(2), 119–131. https://doi.org/10.1038/ncb2012. ArticleCASPubMed Google Scholar
Zhang, C., Lin, M., Wu, R., Wang, X., Yang, B., Levine, A. J., et al. (2011). Parkin, a p53 target gene, mediates the role of p53 in glucose metabolism and the Warburg effect. Proceedings of the National Academy of Sciences of the United States of America, 108(39), 16259–16264. https://doi.org/10.1073/pnas.1113884108. ArticleCASPubMedPubMed Central Google Scholar
Ray-Coquard, I., Blay, J. Y., Italiano, A., Le Cesne, A., Penel, N., Zhi, J., et al. (2012). Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study. The Lancet Oncology, 13(11), 1133–1140. https://doi.org/10.1016/S1470-2045(12)70474-6. ArticleCASPubMed Google Scholar
Ding, Q., Zhang, Z., Liu, J. J., Jiang, N., Zhang, J., Ross, T. M., et al. (2013). Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development. Journal of Medicinal Chemistry, 56(14), 5979–5983. https://doi.org/10.1021/jm400487c. ArticleCASPubMed Google Scholar
Issaeva, N., Bozko, P., Enge, M., Protopopova, M., Verhoef, L. G., Masucci, M., et al. (2004). Small molecule RITA binds to p53, blocks p53-HDM-2 interaction and activates p53 function in tumors. Nature Medicine, 10(12), 1321–1328. https://doi.org/10.1038/nm1146. ArticleCASPubMed Google Scholar
Bykov, V. J., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., et al. (2002). Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound. Nature Medicine, 8(3), 282–288. https://doi.org/10.1038/nm0302-282. ArticleCASPubMed Google Scholar
Yang, Y., Ludwig, R. L., Jensen, J. P., Pierre, S. A., Medaglia, M. V., Davydov, I. V., et al. (2005). Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells. Cancer Cell, 7(6), 547–559. https://doi.org/10.1016/j.ccr.2005.04.029. ArticleCASPubMed Google Scholar
Huang, H. L., Weng, H. Y., Wang, L. Q., Yu, C. H., Huang, Q. J., Zhao, P. P., et al. (2012). Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Molecular Cancer Therapeutics, 11(5), 1155–1165. https://doi.org/10.1158/1535-7163.MCT-12-0066. ArticleCASPubMed Google Scholar
Chan, C. H., Morrow, J. K., Li, C. F., Gao, Y., Jin, G., Moten, A., et al. (2013). Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell, 154(3), 556–568. https://doi.org/10.1016/j.cell.2013.06.048. ArticleCASPubMed Google Scholar
Roy, S., Kaur, M., Agarwal, C., Tecklenburg, M., Sclafani, R. A., & Agarwal, R. (2007). p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Molecular Cancer Therapeutics, 6(10), 2696–2707. https://doi.org/10.1158/1535-7163.MCT-07-0104. ArticleCASPubMed Google Scholar
Yang, E. S., & Burnstein, K. L. (2003). Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. The Journal of Biological Chemistry, 278(47), 46862–46868. https://doi.org/10.1074/jbc.M306340200. ArticleCASPubMed Google Scholar
Zeng, X., Sigoillot, F., Gaur, S., Choi, S., Pfaff, K. L., Oh, D. C., et al. (2010). Pharmacologic inhibition of the anaphase-promoting complex induces a spindle checkpoint-dependent mitotic arrest in the absence of spindle damage. Cancer Cell, 18(4), 382–395. https://doi.org/10.1016/j.ccr.2010.08.010. ArticleCASPubMedPubMed Central Google Scholar
Jiang, J., & Sliva, D. (2010). Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells. International Journal of Oncology, 37(6), 1529–1536. PubMed Google Scholar
Jiang, J., Jedinak, A., & Sliva, D. (2011). Ganodermanontriol (GDNT) exerts its effect on growth and invasiveness of breast cancer cells through the down-regulation of CDC20 and uPA. Biochemical and Biophysical Research Communications, 415(2), 325–329. https://doi.org/10.1016/j.bbrc.2011.10.055. ArticleCASPubMed Google Scholar
Mattern, M. R., Wu, J., & Nicholson, B. (2012). Ubiquitin-based anticancer therapy: carpet bombing with proteasome inhibitors vs surgical strikes with E1, E2, E3, or DUB inhibitors. Biochimica et Biophysica Acta, 1823(11), 2014–2021. https://doi.org/10.1016/j.bbamcr.2012.05.005. ArticleCASPubMed Google Scholar